Owens & Minor investors face 80% loss over three years, despite 3.2% revenue growth.

Owens & Minor (NYSE:OMI) investors have experienced an 80% loss over the past three years, with a 52% decline in the last year and a 16% drop in the last 30 days. Despite a 3.2% revenue increase over three years, the company made a loss in the last twelve months, and its share price has not reflected its underlying business performance.

Owens & Minor Inc. (OMI), a medical supply and logistics company, is set to report its quarterly earnings on July 31, with analysts expecting a 2.3% increase in revenue to $2.731 billion from $2.67 billion a year ago [1]. The company is also anticipated to report earnings of 27 cents per share, according to the mean estimate from six analysts [1]. Despite this expected revenue growth, the company's stock has been volatile, falling 41.9% since the beginning of the year and trading 54.5% below its 52-week high of $16.42 from July 2024 [2].

The recent decline in OMI's stock price can be attributed to broader market sentiment and external factors. In particular, the stock fell 3.5% in the afternoon session after UnitedHealth Group reported disappointing second-quarter results and a weakened outlook for 2025 [2]. This news created a ripple effect across the healthcare sector, leading to a broad-based sell-off. Additionally, concerns about potential new U.S. tariffs on Canadian imports have weighed on investor sentiment, as a trade war could pressure profit margins for companies reliant on cross-border trade [2].

Over the past three years, OMI investors have experienced an 80% loss, with a 52% decline in the last year and a 16% drop in the last 30 days [2]. Despite a 3.2% revenue increase over three years, the company made a loss in the last twelve months, and its share price has not reflected its underlying business performance [2]. The company's share price has been influenced by broader market trends and external factors, rather than its own financial performance.

In conclusion, while Owens & Minor is expected to report a rise in quarterly revenue, the company's stock has been volatile due to broader market sentiment and external factors. Investors should closely monitor the company's earnings report and the broader market trends to assess the potential impact on OMI's stock price.

References:
[1] Reuters. (2025). Owens & Minor Inc. expected to post earnings of 27 cents a share. Retrieved from https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TQ1I4:0-owens-minor-inc-expected-to-post-earnings-of-27-cents-a-share-earnings-preview/
[2] Yahoo Finance. (2025). Why Owens & Minor (OMI) stock fell 3.5% after UnitedHealth Group's disappointing Q2 results. Retrieved from https://finance.yahoo.com/news/why-owens-minor-omi-stock-182545302.html